Niva Bupa Health Insurance Company Limited has informed the Exchange about Transcript

Niva Bupa filed the transcript of its Q4 FY25 earnings call, marking its first full-year results as a listed company (listed November 2024). Gross Written Premium grew 32% on a like-to-like basis to Rs. 7,406 crore (21% on 1/N basis), while Net Earned Premium rose 28% to Rs. 4,894 crore. IFRS profit after tax jumped 91% YoY to Rs. 203 crore, and iGAAP profit grew 161% to Rs. 214 crore. The combined ratio stood at 101.2% on reported basis but improved 270 bps to 96.1% on like-to-like basis, with expense ratio improving 190 bps to 37.4%; management said they are confident of hitting the allowable 35.5% expense of management ratio in FY26. Solvency ratio remained healthy at 3.03x, claims settlement ratio at 92.4%, and NPS improved to 55 from around 50. The company launched a new product 'Rise' targeting the missing middle class, added 8,000 agents and 30 bank/broker partners, and grew retail market share from 9.1% to 9.4%. Retail lives grew ~18% YoY.